Powder: -20°C for 3 years | In solvent: -80°C for 1 year
1. Norisoboldine ((+)-Laurelliptine) might be a potential therapeutic agent for rheumatoid arthritis, and it functions through protecting joint destruction as well as regulating the abnormal immune responses. 2. Norisoboldine inhibits the macrophage activation and the resultant production of pro-inflammatory cytokines via down-regulating the activation of MAPKs signaling pathways rather than NF-κB.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 60.00 |
Description | 1. Norisoboldine ((+)-Laurelliptine) might be a potential therapeutic agent for rheumatoid arthritis, and it functions through protecting joint destruction as well as regulating the abnormal immune responses. 2. Norisoboldine inhibits the macrophage activation and the resultant production of pro-inflammatory cytokines via down-regulating the activation of MAPKs signaling pathways rather than NF-κB. |
Source |
Synonyms | Laurelliptine, (+)-Laurelliptine |
Molecular Weight | 313.35 |
Formula | C18H19NO4 |
CAS No. | 23599-69-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Chloroform, Dichloromethane, Ethyl Acetate, Acetone, etc.: Soluble
DMSO: 56 mg/mL(178.7 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Norisoboldine 23599-69-1 GPCR/G Protein MAPK Neuroscience Adenosine Receptor radix Inhibitor natural alkaloid Laurelliptine orally DSS isoquinoline arthritis linderae inhibit (+)-Laurelliptine P1 receptor inhibitor